Challenges for asthma units in response to COVID-19: a qualitative group dynamics analysis.
Autor: | Martínez Rivera C; Department of Respiratory Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Universitat Autònoma de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red (CIBER) Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain., Crespo-Lessmann A; Department of Respiratory Medicine, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomédica Sant Pau (IIB Sant Pau), Universitat Autònoma de Barcelona, Department of Medicine, Barcelona Respiratory Network (BRN), Barcelona, Spain., Arismendi E; Centro de Investigación Biomédica en Red (CIBER) Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.; Service of Pneumology, Hospital Clínic Barcelona, Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Muñoz-Esquerre M; Department of Respiratory Medicine, Hospital Universitari de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain., Aguilar X; Service of Pneumology, Hospital Universitari Joan XXIII, Unidad Docente Joan XIII, Universitat Rovira i Virgili, Tarragona, Spain., Ausín P; Service of Pneumology, Hospital del Mar-Parc de Salut Mar, Institut Hospital del Mar d'Investigacions Mèdiques, Universitat Pompeu Fabra, Barcelona, Spain., Bobolea I; Centro de Investigación Biomédica en Red (CIBER) Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.; Section of Allergology, Service of Pneumology and Respiratory Allergy, Hospital Clínic Barcelona, Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Dalmau Duch G; Service of Allergology, Hospital Universitari Joan XXIII, Universitat Rovira i Virgili, Tarragona, Spain., Pifarre Teixido R; Service of Pneumology, Hospital Universitari Arnau de Vilanova, Department of Medicine, Universitat de Lleida (UdL), Lleida, Spain., Sabater Talaverano G; Service of Pneumology, Hospital Universitari Dr. Josep Trueta, Girona, Spain., Sogo Sabardía A; Service of Pneumology, Consorci Corporacio Sanitaria Parc Tauli De Sabadell, Sabadell, Barcelona, Spain., Gall XM; Centro de Investigación Biomédica en Red (CIBER) Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.; Service of Pneumology, Hospital Universitari Vall d'Hebron, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Department of Cell Biology, Physiology, and Immunology, Universitat Autònoma de Barcelona, Barcelona, Spain. |
---|---|
Jazyk: | angličtina |
Zdroj: | The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2022 Jun; Vol. 59 (6), pp. 1195-1202. Date of Electronic Publication: 2021 May 08. |
DOI: | 10.1080/02770903.2021.1917605 |
Abstrakt: | Objective: To develop a set of recommendations for the management of severe asthma during COVID-19 pandemic. Methods: Eleven pneumologists and allergologists who were staff members of officially accredited asthma units in Catalonia (Spain) participated in a cross-section study based on three 2-hour virtual workshops (first: brainstorming, second: identification of impacts and challenges summarized in 10 topics, third: establishment of final recommendations by consensus). Results: Impacts and challenges identified were improvement of referral protocols between different levels of care; assessment of the minimum number of function tests to be performed and promote the performance of spirometry in primary care; implementation of videoconferencing, mobile apps, telephone calls, or integral virtual platforms for the follow-up of patients, and definition of the model of care (face-to-face, telematics, mixed) according to the patient's individual needs; self-administration of biologics for domiciliary treatment; and empowerment of the role of nursing and hospital pharmacy in particular for follow-up and self-administration of biologics. The main recommendations included coordination between primary care and specialized care consultation, optimization of lung function testing, implementation of telemedicine, and the role of nursing and hospital pharmacy. Conclusion: The specific proposals in response to the effect of COVID-19 pandemic focused on four areas of interest (coordination between primary care and specialized care, optimization of lung function testing, implementation of telemedicine, and empowerment of the role of nursing and hospital pharmacy) may be generalized to other health care settings, and help to introduce new ways of caring asthma patients in the COVID-19 context. |
Databáze: | MEDLINE |
Externí odkaz: |